Andrew Leo
General Counsel bei Cerevast Medical, Inc.
Profil
Andrew Leo has held multiple positions throughout his career.
Currently, he is the Senior VP-Quality & Regulatory Affairs at Cerevast Medical, Inc. and the Chief Quality Officer at Longevity Biomedical, Inc. In terms of education, Mr. Leo completed his undergraduate degree at the University of Washington and obtained an MBA from the University of Phoenix.
Aktive Positionen von Andrew Leo
| Unternehmen | Position | Beginn |
|---|---|---|
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | General Counsel | 01.08.2015 |
Ausbildung von Andrew Leo
| University of Washington | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cerevast Medical, Inc.
Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Finance |
